Technical Analysis of Indian Equities by Nooresh

Pharma Stocks making a comeback – Sun Pharma , Aurobindo Pharma, Strides Shasun

Auro Blog

Aurobindo Pharma

On verge of a breakout from a triangle.

Sun Pharma blog

Sun Pharma – Breakout with good volumes above 600. A 1 year consolidation.

Strides

Strides Shasun – A major fall but some indications of a turnaround on sustaining 420-430.

 

Disclosure – The stocks have been recommended in our advisory services.

 

1) Technical Analysis Training – Mumbai – 18th-19th August 2018

Trainer – Nooresh Merani & N S Fidai

Payment Link , Course Content & Venue Details - https://www.instamojo.com/analyseindia/technical-analysis-training-mumbai-18th-19th/

2) Technical Analysis Training Bangalore – 25th-26th August 2018

Trainer – N S Fidai

Payment Link , Course Content & Venue Details -  https://www.instamojo.com/analyseindia/technical-analysis-training-bangalore25th-an/

3 ) Technical Analysis Training Delhi – 08th-09th September 2018  -

Trainer – N S Fidai

https://www.instamojo.com/analyseindia/technical-analysis-training-delhi-8th-9th-se/

For our services check link on top of website –

Can subscribe to The Agnostic Portfolio  ( Its down 10-12 % since launch in mid April) .

For Derivatives - http://www.nooreshtech.co.in/quickgains

QuickGains F&O

The product is for traders with a High RIsk Profile and High Risk Apetite. Holding period of positions is 1-15 sessions generally.

DISCLOSURE Nooresh Merani

Securities covered above:  All mentioned in the above post

SEBI Registration disclosure - Investment Adviser ( INA000002991)

Financial Interest:

Nooresh Merani and his family/associates/ analysts would not have exposure in the securities mentioned in the above report/article.

Nooresh Merani and his family/associates/ analysts do not have any financial interest/beneficial ownership of more than 1% in the company covered by Analyst.

Nooresh Merani and his family/associates/ analysts have not received any compensation from the company/third party covered in the above report/article ever.

Nooresh Merani and his family/associates/ analysts  has not served as an officer, director or employee of company covered in the report/article and has not been engaged in market-making activity of the company covered in the report/article.

The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision

Also read the detailed disclaimer - http://www.nooreshtech.co.in/disclaimer

Article by Nooresh Merani

Nooresh has written 2700 articles.

You can follow Nooresh Tech on Facebook and Twitter here.


{ 0 comments… add one }

Leave a Comment